Trial Profile
Phase II study of autism co-morbid for attention deficit hyperactivity disorder.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Apr 2014
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder; Autistic disorder
- Focus Adverse reactions
- 27 Sep 2010 Trial phase changed from II to III as reported by ClinicalTrials.gov.
- 21 Aug 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 21 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.